Related Experiment Video
Updated: Jun 16, 2026

A Murine Model of Dengue Virus-induced Acute Viral Encephalitis-like Disease
Published on: April 28, 2019
Fulminant hepatic failure in an infant with severe dengue infection
R Soundravally1, P Narayanan, B Vishnu Bhat
1Department of Biochemistry, Jawaharlal Institute of Postgraduate and Medical Research, Pondicherry, South India. soundy27@yahoo.co.in
Abstract:
Fulminant hepatic failure due to dengue infection is rare, although mild liver dysfunction is common. Here we report a fatal case of fulminant hepatitis in an infant infected with dengue 3 serotype. Attention must be given to the use of hepatotoxic drugs in some cases of dengue especially in infants.
Insights
Fulminant hepatic failure from dengue infection is rare but can be fatal in infants. Healthcare providers should carefully consider potential drug-induced liver injury in dengue patients, particularly young children.
Area of Science:
- Virology
- Hepatology
- Pediatrics
Background:
- Dengue virus infection commonly causes mild liver dysfunction.
- Fulminant hepatic failure (FHF) is a rare but severe complication of dengue.
Observation:
- This report details a fatal case of dengue 3 serotype infection leading to fulminant hepatitis in an infant.
- The infant presented with severe liver dysfunction.
Findings:
- Dengue virus can cause severe, life-threatening hepatitis, especially in infants.
- Hepatotoxicity associated with certain medications may be exacerbated in dengue patients.
Implications:
- Increased vigilance is required for diagnosing and managing dengue in infants.
- Caution is advised regarding the use of potentially hepatotoxic drugs in infants with dengue infection to prevent severe liver injury.
Related Concept Videos
Hepatic Encephalopathy
Yellow Fever
Diphtheria
Rocky Mountain Spotted Fever
Encephalitis l: Introduction
Pharmacokinetics in Pediatric Patients: Drug Excretion

